Landscape of circulating tumour DNA in metastatic breast cancer
Landscape of circulating tumour DNA in metastatic breast cancer
复制标题
DOI:
10.1016/j.ebiom.2020.102914
复制
发表时间:
2020-08-01
期刊:
影响因子:
11.1
通讯作者:
Cristofanilli, Massimo
中科院分区:
文献类型:
--
作者:
Davis, Andrew A.;Jacob, Saya;Cristofanilli, Massimo
Background: We describe the genomic landscape of circulating tumour DNA (ctDNA) across pathological sub-types of metastatic breast cancer.Methods: 255 clinically annotated patients with ctDNA testing by Guardant360 were stratified into HR+, HER2+, and TNBC cohorts. Frequency and heterogeneity of alterations were reported. Paired ctDNA and tissue sequencing were compared for a subset of patients. The association of ctDNA and metastatic sites of disease on imaging was also assessed.Findings: 89% of patients had at least one ctDNA alteration detected. The most common single nucleotide variants (SNVs) for HR+ patients were PIK3CA, ESR1, and TP53. For HER2+, these were TP53, PIK3CA, and ERBB2 with ERBB2 as the most frequent copy number variant (CNV). For TNBC, the most common SNVs were TP53 and PIK3CA, and the most frequent CNVs were MYC, CCNE1, and PIK3CA. TNBC patients had a significantly higher mutant allele frequency (MAF) of the highest variant compared to HR+ or HER2+ patients (P